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Discussion
Patients with fibrosing alveolitis associated with dermatomyositis are usually classified into two groups.4 5 The first comprises those in whom the pulmonary disease runs an acute course, and in whom histologically there is an acute inflammatory infiltrate in the alveolar wall, which resolves with steroid treatment leaving minimal fibrosis. The patients in the second group follow a chronic progressive course with a poor response to corticosteroids. Schwarz et al described 10 such "steroid-resistant" patients in a review of the published reports.5 Eight of the group had died at the time of reporting, the mean survival period being 40 months. Only two patients, however, died of respiratory failure. The remaining two patients in the "non-responder" group were alive six and seven years after diagnosis. The pulmonary disease in our cases did not respond to steroid treatment and both died in respiratory failure within six months of the onset of symptoms. 
